跳至主要内容
临床试验/NCT03243994
NCT03243994已完成不适用

Small Intestinal Absorption in Patients With Chronic Obstructive Pulmonary Disease Complicated by Cor Pulmonale: A Pilot Study

Jens Rikardt Andersen0 个研究点目标入组 14 人开始时间: 2016年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14
主要终点
Absorption fraction of D-xylose

研究概览

简要总结

Aim: To investigate whether patients with pulmonary hypertension have reduced absorption capacity compared to COPD patients without cor pulmonale potentially due to venous obstruction in the portal vein system.

The presence of cor pulmonale was determined by echocardiography. The concentration of D-xylose and zinc were measured in peripheral blood one, two and three hours after ingestion and used as markers of absorption. Furthermore, urine was collected for five hours to determine the amount of excreted D-xylose.

详细描述

Background: Cor pulmonale is a common complication to Chronic Obstructive Pulmonary Disease (COPD), and may result in increased pressure in the inferior caval vein and stasis of the liver. The chronic pulmonary hypertension may lead to stasis in the veins from the small intestine and thereby compromise absorption of nutrients.

Aim: To investigate whether patients with pulmonary hypertension have reduced absorption capacity compared to COPD patients without cor pulmonale.

Methods: Absorption of D-xylose (25 g) and zinc (132 mg), administered as a single dose, was tested in 14 COPD patients, seven with and seven without cor pulmonale. The presence of cor pulmonale was determined by echocardiography. The concentration of D-xylose and zinc were measured in peripheral blood one, two and three hours after ingestion and used as markers of absorption. Furthermore, urine was collected for five hours to determine the amount of excreted D-xylose.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •A diagnosis of COPD
  • •Clinically stable = Unchanged medication for COPD for at least 6 months

排除标准

  • •Unable to understand Danish
  • •Other clinically important heart-disease than chronic right heart changes presumably due to lung disease
  • •Clinically significant gastro-intestinal or kidney disease
  • •Treatment with corticosteroids for at least 6 months.

研究组 & 干预措施

COPD

Experimental

Patients with COPD without Cor Pulmonale

干预措施: Absorption test with D-xylose and zink (Diagnostic Test)

COPD + Cor Pulmonale

Experimental

Patients with Cor Pulmonale in addition

干预措施: Absorption test with D-xylose and zink (Diagnostic Test)

结局指标

主要结局

Absorption fraction of D-xylose

时间窗: 3 hours

plasma concentration, mmol/l

次要结局

  • Absorption of zinc(3 hours)
  • Absorption fraction of D-xylose(5 hours)

研究者

发起方
Jens Rikardt Andersen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jens Rikardt Andersen

Associate Professor

University of Copenhagen

相似试验